From: A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy
RTOG grade
Acute (62 pts)
I
II
III
IV
Urinary
34%
12%
-
Rectal
27%
18%
Late (9 pts)
4%
3%
1%
2%